SMSLIFE — SMS Lifesciences India Share Price
0.000.00%
Last trade - 00:00- IN₹5.02bn
- IN₹6.08bn
- IN₹3.06bn
- 73
- 26
- 88
- 71
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.67 | ||
| Price to Tang. Book | 2.67 | ||
| Price to Free Cashflow | 26.1 | ||
| Price to Sales | 1.45 | ||
| EV to EBITDA | 12.42 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 13.74% | ||
| Return on Equity | 12.99% | ||
| Operating Margin | 9.84% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 2,607.81 | 2,655.92 | 3,497.45 | 3,155.6 | 3,059.58 | n/a | n/a | -4.13% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -43.3 | +33.43 | +41.73 | -48.7 | -7.69 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
SMS Lifesciences India Limited is an India-based company that is engaged in the business of manufacturing of active pharma ingredients (API) and their intermediates. The Company's API products include Ranitidine Hydrochloride (Form-2) USP / Ph.Eur / IP, Famotidine USP / Ph.Eur / IP, Sildenafil Citrate USP / Ph.Eur / IP, Allopurinol USP / EP / IP, Ropivacaine Hydrochloride USP / EP / IP, Dapsone USP/ EP /BP, Sibutramine Hydrochloride USP, Itraconazole USP / Ph.Eur, Fosphenytoin Sodium USP, Domperidone / Domperidone Maleate EP / IP, Brinzolamide, Tiagabine, Fosaprepitant and Albendazole, among others. Its intermediate offerings include Ranitidine HCl Intermediates, Rizatriptan Intermediates and Imidapril Intermediates. The Company's manufacturing facilities are located at Kazipally and Jeedimetla, and its research and development center at Sanath Nagar in Hyderabad. The Company's wholly owned subsidiary is Mahi Drugs Private Limited.
Directors
- N. Rajendra Prasad CFO
- Trupti Mohanty CCO
- T. Murthy MDR (61)
- Sudeepthl Goplneedl EDR
- Talluri Praveen EDR
- P. Sarath Kumar NID
- Mannam Malakondaiah NID
- P. VenkataSubba Rao NID
- Srinivas Samavedam NID
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 31st, 2006
- Public Since
- August 17th, 2017
- No. of Shareholders
- 8,118
- No. of Employees
- 574
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 3,023,287
- Address
- Plot No:19-III, Road No:71,, HYDERABAD, 500096
- Web
- https://www.smslife.in/
- Phone
- +91 4066288888
- Contact
- Trupti Mohanty
- Auditors
- Rambabu & Co.
Upcoming Events for SMSLIFE
Q1 2026 SMS Lifesciences India Ltd Earnings Release
SMS Lifesciences India Ltd Annual Shareholders Meeting
Similar to SMSLIFE
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the SMS Lifesciences India share price?
As of Today at 23:19 UTC, shares in SMS Lifesciences India are trading at IN₹1,659.70. This share price information is delayed by 15 minutes.
How has the SMS Lifesciences India share price performed this year?
Shares in SMS Lifesciences India last closed at IN₹1,659.70 and the price had moved by +128.92% over the past 365 days. In terms of relative price strength the SMS Lifesciences India share price has outperformed the S&P BSE 100 Index by +112.1% over the past year.
What are the analyst and broker recommendations for SMS Lifesciences India?
There is no consensus recommendation for this security.
Find out moreWhat is the SMS Lifesciences India dividend yield?
The SMS Lifesciences India dividend yield is 0.09% based on the trailing twelve month period.
Does SMS Lifesciences India pay a dividend?
Last year, SMS Lifesciences India paid a total dividend of IN₹1.50, and it currently has a trailing dividend yield of 0.09%. We do not have any data on when SMS Lifesciences India is to next pay dividends.
When does SMS Lifesciences India next pay dividends?
We do not have data on when SMS Lifesciences India is to next pay dividends. The historic dividend yield on SMS Lifesciences India shares is currently 0.09%.
How do I buy SMS Lifesciences India shares?
To buy shares in SMS Lifesciences India you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of SMS Lifesciences India?
As of the previous close price of IN₹1,659.70, shares in SMS Lifesciences India had a market capitalisation of IN₹5.02bn.
Where are SMS Lifesciences India shares listed?
Here are the trading details for SMS Lifesciences India:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: SMSLIFE
What kind of share is SMS Lifesciences India?
Based on an overall assessment of its quality, value and momentum SMS Lifesciences India is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a SMS Lifesciences India share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the SMS Lifesciences India share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like SMS Lifesciences India. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +18.43%.
As of the last closing price of IN₹1,659.70, shares in SMS Lifesciences India were trading +35.41% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the SMS Lifesciences India PE Ratio?
The SMS Lifesciences India PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹1,659.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of SMS Lifesciences India?
SMS Lifesciences India's management team is headed by:
- N. Rajendra Prasad - CFO
- Trupti Mohanty - CCO
- T. Murthy - MDR
- Sudeepthl Goplneedl - EDR
- Talluri Praveen - EDR
- P. Sarath Kumar - NID
- Mannam Malakondaiah - NID
- P. VenkataSubba Rao - NID
- Srinivas Samavedam - NID